BlackRock, Inc. 13D and 13G filings for NeoGenomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-22 3:52 pm Sale |
2023-12-31 | 13G | NeoGenomics, Inc. NEO |
BlackRock Inc. BLK |
19,980,993 15.700% |
-1,951,630![]() (-8.90%) |
Filing |
2023-01-23 3:52 pm Purchase |
2022-12-31 | 13G | NeoGenomics, Inc. NEO |
BlackRock Inc. BLK |
21,932,623 17.400% |
2,604,369![]() (+13.47%) |
Filing |
2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | NeoGenomics, Inc. NEO |
BlackRock Inc. BLK |
19,328,254 15.700% |
0 (Unchanged) |
Filing |
2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | NeoGenomics, Inc. NEO |
BlackRock Inc. BLK |
19,328,254 15.700% |
2,081,684![]() (+12.07%) |
Filing |
2021-01-25 4:50 pm Purchase |
2020-12-31 | 13G | NeoGenomics, Inc. NEO |
BlackRock Inc. BLK |
17,246,570 15.500% |
1,657,438![]() (+10.63%) |
Filing |